Literature DB >> 444542

Phosphorylase kinase from human polymorphonuclear leukocytes.

N B Sørensen.   

Abstract

Phosphorylase kinase from human polymorphonuclear leukocytes was investigated in a gel filtered crude preparation (17,000 x g supernatant). It was found to exist in two forms, one (the phosphorylated form) more active than the other (the dephosphorylated form). Interconversion between the two forms was carried out by a cyclic AMP dependent protein kinase and phosphoprotein phosphatase, respectively. The ratio of activity measured at pH 8.0 and 6.0 was 0.36 for the non-activated and 0.83 for the activated form, which is in contrast to the behaviour of phosphorylase kinase from muscle. Km app for the substrate phosphorylase b was 650 U/ml and 85 U/ml for the non-activated and activated form, respectively, whereas Km app for ATP was 0.03 mM and identical for the two forms. The non-activated form of phosphorylase kinase was activated by Ca2+ in the range 10(-7)--5 . 10(-6) M, which may have physiological importance, whereas the activated form was insensitive to variations in Ca2+ concentration between 10(-9) and 10(-3) M.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444542     DOI: 10.1016/0005-2744(79)90288-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Enzymatic analysis in lymphocytes and erythrocytes from six patients with different phenotypes of phosphorylase kinase deficiency.

Authors:  M Kikuchi; J Aikawa; S Ishizawa; Y Igarashi; K Narisawa; K Tada
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

2.  Phosphorylation of glycogen synthase in a homogenate of human polymorphonuclear leukocytes.

Authors:  H Juhl; V Esmann
Journal:  Mol Cell Biochem       Date:  1981-03-13       Impact factor: 3.396

3.  Cyclic AMP-independent casein/glycogen synthase kinases from pig polymorphonuclear leucocytes.

Authors:  J M Pena; R Cussó; E Itarte
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.